MS

Marina Simian

Oncoliq

CEO

Marina Simian is the CEO and Co-Founder of Oncoliq, a biotech company developing a blood-based platform for early cancer detection using circulating microRNAs and machine learning. With more than 25 years in cancer research and a track record as the first Latin American basic scientist to receive a Susan G. Komen for the Cure Foundation award, she combines deep scientific expertise with entrepreneurial leadership. At Oncoliq, she is advancing scalable, end-to-end screening programs across Latin America and frequently speaks on early detection, innovation, and the translation of science into impact.
Loading